Hamster Antibody Library Construction by Phage Display

Hamster Antibody Library Constructionby Phage Display

Creative Biolabs builds hamster scFv/Fab phage display libraries around the exact species/strain, using sequence-aware primer planning, repertoire QC, and optional downstream screening.

Hamster Antibody Library Construction by Phage Display

Creative Biolabs builds hamster antibody phage display libraries from a defined species/strain and immune source. The service can be placed within custom phage display library construction and coordinated with antibody library construction. Spleen, PBMC/peripheral lymphocytes, other approved B-cell-rich material, RNA, or cDNA can be evaluated, with Fab/scFv format, primer strategy, and QC chosen for the identified hamster source.

The schematic of hamster. (Creative Biolabs Authorized)

Service at a Glance

Hamster Antibody Library Construction by Phage Display service scope
Service ComponentProject Scope
Starting MaterialsSpleen, PBMC/peripheral lymphocytes, other approved B-cell-rich material, RNA, or cDNA from a defined hamster species/strain.
Library FormatsFab or scFv libraries selected according to sequence resources, screening design, and planned downstream format.
Core ConstructionSpecies/strain-aware VH/VL recovery, fragment assembly, cloning, phage rescue, and amplification.
QC OptionsInsert and frame checks, sequence diversity, family representation where annotation permits, display competence, and optional NGS.
Optional Downstream ScreeningPurified-antigen, cell-based, subtractive, or competitive panning with ELISA, flow cytometry, SPR, or BLI confirmation.

Species identification is the central design variable. Syrian hamster, Chinese hamster, and other hamster sources should not be treated as interchangeable for immunoglobulin sequence interpretation or primer planning. The project therefore begins with exact source definition and the sequence resources relevant to that source.

Species/Strain-Aware Repertoire Recovery

Species/Strain-Aware Repertoire Recovery
Planning VariableWhy It MattersProject Response
Exact species and strainDefines which immunoglobulin sequence resources are relevant.Record the source explicitly and avoid transferring primer or annotation assumptions from another hamster species without evidence.
Immune backgroundConnects the recovered repertoire to antigen exposure and collection timing.Preserve immunization/study history with the sample and use it to interpret dominant or expanded sequences.
Primer coverageControls which VH/VL families are sampled during amplification.Select a source-appropriate primer strategy and review amplicon balance or sequence representation where resources permit.
Fragment formatFab and scFv differ in chain architecture and expression context.Choose the format from screening, cloning complexity, and later reformatting requirements.

When sequence annotation is limited, the project plan should state that limitation and use the available evidence to assess major coverage gaps rather than presenting repertoire capture as exhaustive.

Hamster Library Construction Workflow

  1. 01

    Verify the source package.

    Record hamster species/strain, immune background, tissue/cell source, collection timing, storage, and nucleic-acid status.

  2. 02

    Plan and perform VH/VL recovery.

    Generate cDNA when required and select primer sets against the sequence background of the identified hamster source; review amplification profiles for missing or disproportionately strong families where possible.

  3. 03

    Assemble Fab or scFv constructs.

    Define orientation, linker or constant-domain elements, cloning junctions, and reading frame before bulk cloning.

  4. 04

    Create and amplify the display library.

    Clone into a compatible display system, generate phage, and manage bacterial growth and propagation as possible sources of representation bias.

  5. 05

    Release after QC.

    Evaluate insert-positive sampling, sequence quality, diversity/redundancy observations, and display competence before optional panning.

QC and Deliverables

Library Quality

Hamster library QC distinguishes clone-level integrity, sequence diversity, and display competence. Representative sequencing can check complete Fab/scFv architecture, frame, stop codons, and recurrent artifacts. Optional Phage Display NGS Service profiling can expand the view of redundancy, family representation, CDR distributions, and propagation-associated frequency shifts when annotation resources support those analyses.

Creative Biolabs can provide a construction deliverable that includes the library material, clone/titer measurements, insert and sequence-sampling results, diversity observations, display-related QC, and a technical report. The exact package is defined from sample quality and downstream use.

Downstream Selection

Hamster Library Screening and Confirmation

Purified protein, peptide, membrane target, and cell-surface target formats can require different selection interfaces. If panning is included, direct, cell-based, subtractive, or competitive elements are selected around the target presentation and the background that must be controlled. The qualified library can proceed to Immunized Library Screening when candidate enrichment is part of the program.

After enrichment, ELISA, flow cytometry, SPR, or BLI can be used according to the binding question and antigen format. When a selected Fab or scFv is reformatted into another antibody architecture, binding should be reconfirmed in the new molecular context.

What to Send Us

Feasibility Review
Laboratory researcher working in a lab. (Creative Biolabs Authorized)

For a focused feasibility review, send the following project information for the hamster library:

Project Information
  • Species / strain: exact hamster species/strain and source information
  • Sample type: available cells, tissue, RNA, or cDNA
  • Immune history: immunization, exposure, or study background
  • Collection timing: sampling point relative to immunization or the study design
  • RNA / cDNA status: material condition, available quantity, and existing quality information
  • Desired format: scFv or Fab, plus any anticipated reformatting
  • Screening / QC requirement: target presentation, selection controls, candidate-confirmation needs, and QC depth

Creative Biolabs can use these inputs to define a research-use-only construction plan and, when requested, connect it to downstream screening and candidate confirmation.

Published Data

Amino-acid alignment of hamster immunoglobulin light chains highlighting CDR regions and sequence variation among hamster antibodies. (OA Literature)
Fig.1 Amino-acid sequence alignment of the HL4E10 hamster IgG light chain with those of other hamster antibodies. 1
01 / LITERATURE EVIDENCEPublished Data

Available hamster immunoglobulin sequence data remain much less extensive than for commonly used mouse or human systems, which makes source definition especially important during library planning. One detailed study characterized the complete cDNA sequence and Fab structure of an Armenian hamster IgG and reported a lambda light chain at a time when previously deposited hamster IgG sequences were limited to kappa-chain examples. Sequence comparisons showed that this lambda chain was substantially different from the known hamster kappa sequences, while the heavy chain also added to a very small set of complete hamster antibody sequences. The work does not establish repertoire-wide frequencies or validate a phage-display library, but it provides direct evidence that hamster antibody sequence space cannot be represented reliably by a narrow set of previously characterized chains. For hamster library construction, the appropriate conclusion is therefore conservative: species and strain should be defined explicitly, primer and annotation choices should be based on the best available sequence information for that source, and incomplete reference coverage should be acknowledged when interpreting VH/VL recovery and apparent diversity.

Project FAQs

Does hamster species affect primer and library design?
Yes. The exact species and strain determine which immunoglobulin sequence information is appropriate for primer selection and sequence interpretation. A strategy developed for one hamster source should be transferred to another only when the relevant sequence evidence supports it.
Can both Fab and scFv formats be considered?
Yes. Fab retains separate heavy- and light-chain components and additional domain context, whereas scFv joins the variable regions in one chain. The best choice depends on sequence resources, vector design, screening format, expression behavior, and anticipated reformatting.
How are phage hits confirmed after screening?
Selected clones are sequenced and tested with an assay suited to the target, such as ELISA, flow cytometry, SPR, or BLI. If the fragment is moved into IgG or another format, the reformatted molecule is tested again in that context.
Can material from different hamster species or strains be combined?
Only with a defined design rationale. Different hamster sources can require different immunoglobulin sequence references, primer strategies, and annotation assumptions. When mixed-source material is scientifically justified, separate recovery or sublibrary QC can help preserve provenance before any deliberate pooling step.
What if hamster immunoglobulin annotation is incomplete?
The project should use the best available species-specific sequence information and describe primer coverage conservatively. Reaction grouping, representative sequencing, and optional deeper repertoire profiling can help identify major family dropout or overrepresentation without claiming exhaustive recovery of an incompletely annotated repertoire.

Reference

  1. Verdino, Petra, et al. "cDNA Sequence and Fab Crystal Structure of HL4E10, a Hamster IgG Lambda Light Chain Antibody Stimulatory for γδ T Cells." PLOS ONE 6.5 (2011): e19828. Distributed under the Creative Commons Attribution License (CC BY), without modification. https://doi.org/10.1371/journal.pone.0019828.
×
Online Inquiry

Please kindly note that our services can only be used to support research purposes (Not for clinical use).

Biophage Technology

Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.

Contact Us
  • Global Locations
Privacy Policy | Cookie Policy | Copyright © 2026 Creative Biolabs. All rights reserved.